Health & Biotech
Leaving out ladies could be costing biotechs a lot of money
Health software still attractive to buyers despite COVID market crisis
Clinuvel ready to sell its skin disorder treatment in the US; next up — a treatment that might have cured Michael Jackson
Health Kick Podcast: Understanding immunotherapy, why the drug market dried up and Immutep’s profitable potential
ASX cracks down on coronavirus claims
Check up: The COVID-crisis strikes leaving just 9 stocks in the black
New probiotic bio-fermented drink ‘the bee’s knees’ in lucrative market
Dimerix stays on track for a big year in 2020 as market volatility spikes
TBG says reason for pre-halt price jump was Europe COVID-19 kit nod
Zero to Hero: How Avita Medical rose over 500 per cent in 2 years
Health: Even bacteria fighter Next Science is feeling the coronavirus pinch
MMJ Holdings stays flexible on capital strategy, offers improved terms to investors
Health: Alcidion reckons its tech is crucial in the fight against coronavirus
Dr Boreham’s Crucible: Why unlisted Qbiotics has a good chance of cracking the cancer market
Health: Biotron’s anti-HIV therapy could mean patients may not need treatment forever
Gone viral: COVID-19 is making Jatenergy, AuMake so very rich
Your guide to COVID-19 vaccines: it’ll all be over soon
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
